Previously treated cases tested for RR-/MDR-TB (%) in Guatemala
Guatemala: Previously treated cases tested for RR-/MDR-TB was 85.0% in 2024. ◆ Volatile
Previously treated cases tested for RR-/MDR-TB in Guatemala, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Guatemala recorded 85.0% for previously treated cases tested for rr-/mdr-tb in 2024.
That represents a change of up 4.9% on the previous year and up 23.2% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Guatemala peaked at 100.0% in 2009 and was at its lowest, 0.0%, in 2007.
Guatemala ranks 100th of 180 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Previously treated cases tested for RR-/MDR-TB in Guatemala, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 25.0% | — |
| 2007 | 0.0% | -100.0% |
| 2008 | 18.0% | — |
| 2009 | 100.0% | +455.6% |
| 2010 | 9.9% | -90.1% |
| 2011 | 17.0% | +71.7% |
| 2012 | 37.0% | +117.6% |
| 2013 | 54.0% | +45.9% |
| 2014 | 69.0% | +27.8% |
| 2015 | 52.0% | -24.6% |
| 2016 | 57.0% | +9.6% |
| 2017 | 57.0% | +0.0% |
| 2018 | 52.0% | -8.8% |
| 2019 | 87.0% | +67.3% |
| 2020 | 100.0% | +14.9% |
| 2021 | 95.0% | -5.0% |
| 2022 | 95.0% | +0.0% |
| 2023 | 81.0% | -14.7% |
| 2024 | 85.0% | +4.9% |
Guatemala compared with similar countries
- Guatemala's 85.0% is below the median for upper middle income countries, which is 92.0%, 92% of the median. (52 countries reporting)
- Guatemala's 85.0% is above the median for Latin America & Caribbean, which is 85.0%, 1.0× the median. (29 countries reporting)
Biggest year-on-year movements
Years where Previously treated cases tested for RR-/MDR-TB in Guatemala changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2009 | +455.6% | 18.0% | 100.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 35.8% | 0.0% | 100.0% | 4 |
| 2010s | 49.2% | 9.9% | 87.0% | 10 |
| 2020s | 91.2% | 81.0% | 100.0% | 5 |
Countries ranked near Guatemala
More health data for Guatemala
- Un projection of annual infant deaths, annual growth rate -1.92 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7968 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,202 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,022 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.4059 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0487 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.3488 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Guatemala?
- Previously treated cases tested for rr-/mdr-tb in Guatemala was 85.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Guatemala?
- The highest recorded value was 100.0% in 2009.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Guatemala?
- The lowest recorded value was 0.0% in 2007.
- How does Guatemala rank for previously treated cases tested for rr-/mdr-tb?
- Guatemala ranks 100th out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Guatemala?
- Over the last ten years it is up 23.2%. The long-run trend across the full record is volatile.
- Where does this Guatemala data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 19 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).